Back to Startups

Immunocore

Bioscience & Disease Healthcare Systems
Bioscience & Disease Healthcare Systems Show less
Bioscience & Disease Healthcare Systems
Bioscience & Disease Healthcare Systems Show less
@Immunocore Website LinkedIn Oxford
About Immunocore

Immunocore is a leading biotechnology company focused on developing innovative therapies for cancer and other serious diseases using its proprietary T-cell receptor technology. The company aims to harness the power of the immune system to create effective treatments that can target and destroy cancer cells.

Business Information
Target Customers
healthcare providers pharmaceutical companies research institutions
Industry Categories
Bioscience & Disease Healthcare Systems
Business Model
Revenue Model Partnerships and collaborations
Pricing Strategy N/A
Sales Channels direct sales, partnerships
Funding Timeline
Round Date Amount Investors
Series B Aug 18, 2025 $205.0M Unknown
Founders

No founder information available.

Investors

No investor information available.

Recent Mentions
OlenMust
Anthony Ao @OlenMust
Aug 18, 2025

🇬🇧 UK's Immunocore raised a record £205M series B. Europe's largest biotech VC round ever! Track trends ➡️ https://t.co/lW9YbRe17e

View on Twitter
Similar Startups
Tcelltech
89% match

Tcelltech is a clinical-stage biopharma focused on developing immunotherapies.
Avammune Therapeutics
88% match

Avammune Therapeutics is a biopharmaceutical company focused on small molecule drug discovery and de...
Robocore
88% match

Robocore is a technology-driven startup focused on revolutionizing healthcare through innovative sol...
BioTroy Therapeutics
87% match

BioTroy Therapeutics is a biotechnology company focused on developing innovative anti-tumor therapeu...